Showing results (1031-1040 of 1,341) with videos related to
Sort By:
Pageof 135
Neuro-Oncology Advances|October 1, 2021
Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell culturesCassandra Verheul, Ioannis Ntafoulis, Trisha V Kers, et al.Neuro-Oncology Advances|April 14, 2022
The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumabRenske Gahrmann, Marion Smits, René Michel Vernhout, et al.Neuro-Oncology Advances|March 16, 2022
Clinical trials targeting neurofibromatoses-associated tumors: a systematic reviewGabriel Roman Souza, Ahmed Abdalla, Daruka MahadevanNeuro-Oncology Advances|January 12, 2023
Corrigendum to: Epigenetic dysregulation in meningiomasNeuro-Oncology Advances|January 5, 2023
Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapyTomoyoshi Nakagawa, Noriyuki Kijima, Kana Hasegawa, et al.Neuro-Oncology Advances|September 1, 2021
Systematic review-Time to malignant transformation in low-grade gliomas: Predicting a catastrophic event with clinical, neuroimaging, and molecular markersZabina Satar, Gary Hotton, George SamandourasNeuro-Oncology Advances|May 20, 2021
H3K27M and TERT promoter mutations are poor prognostic factors in surgical cases of adult thalamic high-grade gliomaYoshinari Osada, Ryuta Saito, Ichiyo Shibahara, et al.Neuro-Oncology Advances|May 20, 2021
Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changesFrancesco D'Amore, Farida Grinberg, Jörg Mauler, et al.Neuro-Oncology Advances|May 19, 2021
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessmentMaciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, et al.Neuro-Oncology Advances|August 2, 2021
Expression of cell type incongruent alpha-cardiac actin 1 subunit in medulloblastoma reveals a novel mechanism for cancer cell survival and control of migrationRahul Suresh, Daniel Picard, Rita Lo, et al.Pageof 135